{"name":"5AM Ventures","permalink":"5am-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/5am-ventures","homepage_url":"http://www.5amventures.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"650-233-8600","description":"Venture capital Firm","email_address":"","number_of_employees":null,"founded_year":2002,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Mar 11 17:52:18 UTC 2009","updated_at":"Mon Jun 08 09:20:03 UTC 2009","overview":"<p>5AM Ventures is a seed and early-stage venture capital firm focused on building next-generation life science companies.  Founded in 2002, 5AM Ventures has over $200 million under management and is actively investing its second fund.  The firm has offices in Menlo Park, CA and Waltham, MA.</p>","image":{"available_sizes":[[[149,105],"assets/images/resized/0004/7316/47316v1-max-150x150.png"],[[149,105],"assets/images/resized/0004/7316/47316v1-max-250x250.png"],[[149,105],"assets/images/resized/0004/7316/47316v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"Menlo Park, CA ","address1":"2200 Sand Hill Road ","address2":"Suite 110","zip_code":"94025","city":"Menlo Park","state_code":"CA","country_code":"USA","latitude":37.422876,"longitude":-122.199368},{"description":"Waltham, MA","address1":"Waltham Woods Corporate Center","address2":"890 Winter Street, Suite 140 ","zip_code":"02451","city":"Waltham","state_code":"MA","country_code":"USA","latitude":null,"longitude":null}],"relationships":[{"is_past":false,"title":"Principal","person":{"first_name":"Mark","last_name":"S. Colella","permalink":"mark-s-colella","image":{"available_sizes":[[[150,147],"assets/images/resized/0004/7317/47317v1-max-150x150.jpg"],[[161,158],"assets/images/resized/0004/7317/47317v1-max-250x250.jpg"],[[161,158],"assets/images/resized/0004/7317/47317v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Principal","person":{"first_name":"Andrew","last_name":"McMillan","permalink":"andrew-mcmillan","image":{"available_sizes":[[[150,150],"assets/images/resized/0004/7319/47319v1-max-150x150.jpg"],[[160,160],"assets/images/resized/0004/7319/47319v1-max-250x250.jpg"],[[160,160],"assets/images/resized/0004/7319/47319v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Principal","person":{"first_name":"Kevin","last_name":"Forrest","permalink":"kevin-forrest","image":{"available_sizes":[[[145,150],"assets/images/resized/0004/7318/47318v1-max-150x150.jpg"],[[155,160],"assets/images/resized/0004/7318/47318v1-max-250x250.jpg"],[[155,160],"assets/images/resized/0004/7318/47318v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"a","source_url":"http://venturebeat.com/2007/10/29/amgen-relypsa-and-the-art-of-the-biotech-spinout-startup-restart/","source_description":"Amgen, Relypsa and the art of the biotech-spinout-startup-restart","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":29,"company":{"name":"Relypsa","permalink":"relypsa","image":{"available_sizes":[[[150,79],"assets/images/resized/0003/7781/37781v1-max-150x150.png"],[[250,132],"assets/images/resized/0003/7781/37781v1-max-250x250.png"],[[292,155],"assets/images/resized/0003/7781/37781v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/synosia-raises-29m-phase-ii-testing/2009-01-07","source_description":"Synosia raises $29M for Phase II testing","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":null,"company":{"name":"Synosia Therapeutics","permalink":"synosia-therapeutics","image":{"available_sizes":[[[150,49],"assets/images/resized/0004/3264/43264v1-max-150x150.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-250x250.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.anaphoreinc.com/news.htm","source_description":"April 15, 2008 - Anaphore Receives $8M In Financing","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":4,"funded_day":15,"company":{"name":"Anaphore","permalink":"anaphore","image":{"available_sizes":[[[150,37],"assets/images/resized/0004/7312/47312v2-max-150x150.png"],[[245,62],"assets/images/resized/0004/7312/47312v2-max-250x250.png"],[[245,62],"assets/images/resized/0004/7312/47312v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.kalobios.com/kb_news_2008_12_22.php","source_description":"KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":12,"funded_day":22,"company":{"name":"KaloBios Pharmaceuticals","permalink":"kalobios-pharmaceuticals","image":{"available_sizes":[[[150,42],"assets/images/resized/0004/8539/48539v1-max-150x150.jpg"],[[161,46],"assets/images/resized/0004/8539/48539v1-max-250x250.jpg"],[[161,46],"assets/images/resized/0004/8539/48539v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/anaphore-inc-series-a-13m/","source_description":"Anaphore, Inc.: Series A $13M","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":9,"company":{"name":"Anaphore","permalink":"anaphore","image":{"available_sizes":[[[150,37],"assets/images/resized/0004/7312/47312v2-max-150x150.png"],[[245,62],"assets/images/resized/0004/7312/47312v2-max-250x250.png"],[[245,62],"assets/images/resized/0004/7312/47312v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://us.ellre.com/a-jjkda2bzTPV","source_description":"Semrus BioSciences Raises $8 Million","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":12,"funded_day":14,"company":{"name":"Semprus BioSciences","permalink":"semprus-biosciences","image":{"available_sizes":[[[150,36],"assets/images/resized/0004/9007/49007v1-max-150x150.jpg"],[[244,59],"assets/images/resized/0004/9007/49007v1-max-250x250.jpg"],[[244,59],"assets/images/resized/0004/9007/49007v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Capital Report Index","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":10,"funded_day":20,"company":{"name":"S*Bio","permalink":"s-bio","image":{"available_sizes":[[[150,61],"assets/images/resized/0004/8400/48400v1-max-150x150.png"],[[195,80],"assets/images/resized/0004/8400/48400v1-max-250x250.png"],[[195,80],"assets/images/resized/0004/8400/48400v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/ambrx-inc-series-d-10m/","source_description":"Ambrx, Inc.: Series D $10M","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":1,"company":{"name":"Ambrx","permalink":"ambrx","image":{"available_sizes":[[[150,53],"assets/images/resized/0004/1068/41068v1-max-150x150.png"],[[194,69],"assets/images/resized/0004/1068/41068v1-max-250x250.png"],[[194,69],"assets/images/resized/0004/1068/41068v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://deals.venturebeat.com/2008/07/03/pearl-therapeutics-ups-its-first-round-funding/","source_description":"Pearl Therapeutics ups its first round funding","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":7,"funded_day":3,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2007/01/05/neurological-co-synosis-raises-325m/","source_description":"Neurological co. Synosis raises $32.5M","raised_amount":32500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":1,"funded_day":5,"company":{"name":"Synosia Therapeutics","permalink":"synosia-therapeutics","image":{"available_sizes":[[[150,49],"assets/images/resized/0004/3264/43264v1-max-150x150.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-250x250.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2008/01/31/5am-ventures-puts-33m-into-stealthy-immunology-startup-immunonewco/","source_description":"5AM Ventures puts $3.3M into stealthy immunology startup ImmunoNewco","raised_amount":3300000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":31,"company":{"name":"Anaphore","permalink":"anaphore","image":{"available_sizes":[[[150,37],"assets/images/resized/0004/7312/47312v2-max-150x150.png"],[[245,62],"assets/images/resized/0004/7312/47312v2-max-250x250.png"],[[245,62],"assets/images/resized/0004/7312/47312v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://earth2tech.com/2009/09/18/rennovia-grabs-12m-for-renewable-chemicals/http://earth2tech.com/2009/09/18/rennovia-grabs-12m-for-renewable-chemicals/","source_description":"Rennovia Grabs $12M for Renewable Chemicals","raised_amount":12300000,"raised_currency_code":"USD","funded_year":2009,"funded_month":9,"funded_day":18,"company":{"name":"Rennovia","permalink":"rennovia","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/story/flexion-garners-33m-series/2009-10-19?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Flexion garners $33M in Series A","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":1,"company":{"name":"Flexion Therapeutics","permalink":"flexion-therapeutics","image":{"available_sizes":[[[140,56],"assets/images/resized/0006/3158/63158v1-max-150x150.png"],[[140,56],"assets/images/resized/0006/3158/63158v1-max-250x250.png"],[[140,56],"assets/images/resized/0006/3158/63158v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.xconomy.com/boston/2009/11/02/pulmatrix-scores-30m-venture-round-for-lung-drug-that-defends-against-multiple-bugs/","source_description":"Xconomy Boston","raised_amount":30200000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":2,"company":{"name":"Pulmatrix","permalink":"pulmatrix","image":{"available_sizes":[[[150,48],"assets/images/resized/0006/5853/65853v1-max-150x150.png"],[[188,61],"assets/images/resized/0006/5853/65853v1-max-250x250.png"],[[188,61],"assets/images/resized/0006/5853/65853v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.masshightech.com/stories/2009/03/09/weekly12-Pulmatrix-pulls-in-3M-in-new-venture-round.html","source_description":"Mass High Tech","raised_amount":3500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":3,"funded_day":11,"company":{"name":"Pulmatrix","permalink":"pulmatrix","image":{"available_sizes":[[[150,48],"assets/images/resized/0006/5853/65853v1-max-150x150.png"],[[188,61],"assets/images/resized/0006/5853/65853v1-max-250x250.png"],[[188,61],"assets/images/resized/0006/5853/65853v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.biospace.com/news_story.aspx?NewsEntityId=87665","source_description":"Biotech Startup PhaseRx Wins $19M Pledge","raised_amount":19000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":2,"funded_day":28,"company":{"name":"PhaseRx","permalink":"phaserx","image":{"available_sizes":[[[150,40],"assets/images/resized/0007/0530/70530v1-max-150x150.jpg"],[[194,53],"assets/images/resized/0007/0530/70530v1-max-250x250.jpg"],[[194,53],"assets/images/resized/0007/0530/70530v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/pearl-therapeutics-inc-series-c-15m/","source_description":"Pearl Therapeutics, Inc.: Series C $15M","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":5,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.variationbiotech.com/VBI%20Financing%20Press%20Release%20v1.4.pdf","source_description":"Variation Biotechnologies Secures US$35.7 Million in Series A Financing to Fund Innovative Vaccine Platform","raised_amount":35700000,"raised_currency_code":"USD","funded_year":2007,"funded_month":1,"funded_day":4,"company":{"name":"Variation Biotechnologies","permalink":"variation-biotechnologies","image":{"available_sizes":[[[150,64],"assets/images/resized/0007/9952/79952v1-max-150x150.jpg"],[[250,108],"assets/images/resized/0007/9952/79952v1-max-250x250.jpg"],[[259,112],"assets/images/resized/0007/9952/79952v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.marcadiabiotech.com/images/PRESS%20RELEASE%202007_05_15%20FINAL.pdf","source_description":"MARCADIA BIOTECH COMPLETES $15 MILLION SERIES A FINANCING","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":5,"funded_day":15,"company":{"name":"Marcadia Biotech","permalink":"marcadia-biotech","image":{"available_sizes":[[[150,41],"assets/images/resized/0008/0209/80209v1-max-150x150.jpg"],[[250,68],"assets/images/resized/0008/0209/80209v1-max-250x250.jpg"],[[319,88],"assets/images/resized/0008/0209/80209v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.pr-inside.com/achaogen-completes-56-million-series-c-r1817734.htm","source_description":"Achaogen Completes $56 Million Series C Financing ","raised_amount":56000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":7,"company":{"name":"Achaogen","permalink":"achaogen","image":{"available_sizes":[[[150,39],"assets/images/resized/0008/3158/83158v1-max-150x150.png"],[[197,52],"assets/images/resized/0008/3158/83158v1-max-250x250.png"],[[197,52],"assets/images/resized/0008/3158/83158v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.achaogen.com/news/2/52","source_description":"Achaogen Closes Series B Financing","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":10,"funded_day":10,"company":{"name":"Achaogen","permalink":"achaogen","image":{"available_sizes":[[[150,39],"assets/images/resized/0008/3158/83158v1-max-150x150.png"],[[197,52],"assets/images/resized/0008/3158/83158v1-max-250x250.png"],[[197,52],"assets/images/resized/0008/3158/83158v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":1000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":3,"funded_day":1,"company":{"name":"Marcadia Biotech","permalink":"marcadia-biotech","image":{"available_sizes":[[[150,41],"assets/images/resized/0008/0209/80209v1-max-150x150.jpg"],[[250,68],"assets/images/resized/0008/0209/80209v1-max-250x250.jpg"],[[319,88],"assets/images/resized/0008/0209/80209v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/igenica-inc-series-b-24m/","source_description":"Igenica, Inc.: Series B $24M","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":14,"company":{"name":"Igenica","permalink":"igenica","image":{"available_sizes":[[[150,65],"assets/images/resized/0009/0611/90611v1-max-150x150.jpg"],[[250,109],"assets/images/resized/0009/0611/90611v1-max-250x250.jpg"],[[265,116],"assets/images/resized/0009/0611/90611v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/incline-therapeutics-inc-series-a-43m/","source_description":"Incline Therapeutics, Inc.: Series A $43M","raised_amount":43000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":28,"company":{"name":"Incline Therapeutics","permalink":"incline-therapeutics","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2010/09/relypsa-raises-70m-in-series-b.html","source_description":"Relypsa Raises $70M in Series B Financing","raised_amount":70000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":13,"company":{"name":"Relypsa","permalink":"relypsa","image":{"available_sizes":[[[150,79],"assets/images/resized/0003/7781/37781v1-max-150x150.png"],[[250,132],"assets/images/resized/0003/7781/37781v1-max-250x250.png"],[[292,155],"assets/images/resized/0003/7781/37781v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/pearl-lands-69m-series-c-mid-stage-copd-program/2010-10-19?utm_medium=rss&utm_source=rss","source_description":"Pearl lands $69M Series C for mid-stage COPD program","raised_amount":69000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":19,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.synosia.com/list-details.aspx?listguid=E8469572-06DC-475F-9815-2A91E1232F9A&folderguid=801EEB72-27A8-495F-8A19-242E20F5F875","source_description":"Synosia Therapeutics Raises $30M in Series C Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":12,"company":{"name":"Synosia Therapeutics","permalink":"synosia-therapeutics","image":{"available_sizes":[[[150,49],"assets/images/resized/0004/3264/43264v1-max-150x150.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-250x250.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.semprusbio.com/documents/SEMPRUS_BIOSCIENCES_RAISES_ADDITIONAL_18_MILLION.pdf","source_description":"SEMPRUS BIOSCIENCES RAISES ADDITIONAL $18 MILLION","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":12,"funded_day":13,"company":{"name":"Semprus BioSciences","permalink":"semprus-biosciences","image":{"available_sizes":[[[150,36],"assets/images/resized/0004/9007/49007v1-max-150x150.jpg"],[[244,59],"assets/images/resized/0004/9007/49007v1-max-250x250.jpg"],[[244,59],"assets/images/resized/0004/9007/49007v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/07/dvs-sciences-completes-14-6m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"DVS Sciences Completes $14.6M Series A Financing","raised_amount":14600000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":14,"company":{"name":"DVS Sciences","permalink":"dvs-sciences","image":{"available_sizes":[[[150,27],"assets/images/resized/0014/4332/144332v1-max-150x150.png"],[[226,41],"assets/images/resized/0014/4332/144332v1-max-250x250.png"],[[226,41],"assets/images/resized/0014/4332/144332v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://eon.businesswire.com/news/eon/20110815005533/en/pulmatrix/inhaled-drug-delivery/respiratory-disease","source_description":"Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis","raised_amount":14000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":15,"company":{"name":"Pulmatrix","permalink":"pulmatrix","image":{"available_sizes":[[[150,48],"assets/images/resized/0006/5853/65853v1-max-150x150.png"],[[188,61],"assets/images/resized/0006/5853/65853v1-max-250x250.png"],[[188,61],"assets/images/resized/0006/5853/65853v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/10/cleave-biosciences-raises-42m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Cleave Biosciences Raises $42M in Series A Financing","raised_amount":42000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":11,"company":{"name":"Cleave Biosciences","permalink":"cleave-biosciences","image":null}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/06/igenica-raises-33m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Igenica Raises $33M in Series C Funding","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":12,"company":{"name":"Igenica","permalink":"igenica","image":{"available_sizes":[[[150,65],"assets/images/resized/0009/0611/90611v1-max-150x150.jpg"],[[250,109],"assets/images/resized/0009/0611/90611v1-max-250x250.jpg"],[[265,116],"assets/images/resized/0009/0611/90611v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/08/atterocor-raises-16m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Atterocor Raises $16M in Series A Funding","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":8,"funded_day":3,"company":{"name":"Atterocor","permalink":"atterocor","image":{"available_sizes":[[[150,37],"assets/images/resized/0020/4327/204327v1-max-150x150.png"],[[249,63],"assets/images/resized/0020/4327/204327v1-max-250x250.png"],[[249,63],"assets/images/resized/0020/4327/204327v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/08/novira-therapeutics-secures-23m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Novira Therapeutics Secures $23M in Series A Financing","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":8,"funded_day":24,"company":{"name":"Novira Therapeutics","permalink":"novira-therapeutics","image":{"available_sizes":[[[150,39],"assets/images/resized/0014/6325/146325v1-max-150x150.png"],[[250,65],"assets/images/resized/0014/6325/146325v1-max-250x250.png"],[[317,83],"assets/images/resized/0014/6325/146325v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2012/11/pearl-therapeutics-raises-65m-series-financing.html","source_description":"Pearl Therapeutics Raises $65M in Series D Financing","raised_amount":65000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":13,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.reuters.com/article/2012/12/04/idUS44157+04-Dec-2012+PRN20121204","source_description":"Flexion Therapeutics Secures $20 Million in Series B Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":12,"funded_day":4,"company":{"name":"Flexion Therapeutics","permalink":"flexion-therapeutics","image":{"available_sizes":[[[140,56],"assets/images/resized/0006/3158/63158v1-max-150x150.png"],[[140,56],"assets/images/resized/0006/3158/63158v1-max-250x250.png"],[[140,56],"assets/images/resized/0006/3158/63158v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"5AM Ventures III","funded_year":2009,"funded_month":12,"funded_day":11,"raised_amount":197835000,"raised_currency_code":"USD","source_url":"http://www.sec.gov/Archives/edgar/data/1456890/000145689009000004/xslFormDX01/primary_doc.xml","source_description":"SEC"},{"name":"5AM Ventures II","funded_year":2006,"funded_month":null,"funded_day":null,"raised_amount":150000000,"raised_currency_code":"USD","source_url":"http://www.altassets.com/private-equity-news/article/nz17486.html","source_description":"AltAssets"},{"name":"5AM Ventures I","funded_year":2002,"funded_month":null,"funded_day":null,"raised_amount":65000000,"raised_currency_code":"USD","source_url":"http://www.altassets.com/private-equity-news/article/nz17486.html","source_description":"AltAssets"},{"name":"5AM Co-Investors III","funded_year":2009,"funded_month":12,"funded_day":17,"raised_amount":2115000,"raised_currency_code":"USD","source_url":"http://www.sec.gov/Archives/edgar/data/1478660/000147866009000001/xslFormDX01/primary_doc.xml","source_description":"SEC D"},{"name":"5AM Co-Investors III","funded_year":2010,"funded_month":2,"funded_day":25,"raised_amount":3370000,"raised_currency_code":"USD","source_url":"http://www.sec.gov/Archives/edgar/data/1478660/000147866010000001/xslFormDX01/primary_doc.xml","source_description":"SEC D/A"}],"video_embeds":[],"external_links":[]}